Product image of Paracetamol/Ibuprofene Medipha (Ibuprofen, Paracetamol) supplied by GNH India

Paracetamol/Ibuprofene Medipha

Active Ingredient:
Ibuprofen, Paracetamol
Origin:
EU

Paracetamol/Ibuprofene Medipha (Ibuprofen, Paracetamol)

Ibuprofen, the active ingredient in Paracetamol/Ibuprofene Medipha, is a non‑steroidal anti‑inflammatory drug presented as a combined formulation for oral use. It relieves pain, reduces fever and decreases inflammation in adults and children when used as directed.
GNH India supplies Paracetamol/Ibuprofene Medipha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medipha Sante

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Paracetamol/Ibuprofene Medipha combines two well‑known analgesic‑antipyretic agents that act on pain‑related and inflammatory pathways. It is indicated for:

  • Headache: provides rapid relief of mild to moderate headache pain.
  • Dental pain: helps control postoperative dental discomfort.
  • Musculoskeletal pain: reduces inflammation‑associated pain from strains, sprains and low‑back tension.
  • Fever: lowers elevated body temperature in febrile adults and children.
  • Minor arthritic pain: eases discomfort from osteoarthritis flares.

How It Works

  • Ibuprofen inhibits cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing prostaglandin synthesis that mediates inflammation, pain and fever. Paracetamol’s exact mechanism is not fully understood but is thought to act centrally to inhibit a variant of COX and modulate serotonergic pathways, providing additional analgesic and antipyretic effects.

Side Effects

Paracetamol/Ibuprofene Medipha may cause a range of adverse reactions.

Common Side Effects

  • Gastrointestinal discomfort: mild nausea, dyspepsia or heartburn.
  • Headache: transient worsening of headache.
  • Dizziness: light‑headed sensation.
  • Skin reddening: mild flushing.
  • Elevated liver enzymes: mild, reversible changes in blood tests.

Serious or Rare Side Effects

  • Gastrointestinal ulceration or bleeding.
  • Severe skin reactions such as Stevens‑Johnson syndrome.
  • Hepatotoxicity: significant liver injury, especially with overdose.
  • Renal impairment: reduced kidney function or acute failure.
  • Anaphylaxis: rapid onset of swelling, hives and airway compromise.

Precautions & Warnings

When using Paracetamol/Ibuprofene Medipha, consider the following safety measures:

  • Assess renal function: avoid use in severe chronic kidney disease.
  • Monitor hepatic health: caution in patients with liver disease or chronic alcohol use.
  • Avoid concurrent NSAID use: reduces risk of gastrointestinal bleeding.
  • Use lowest effective dose: limit duration to the shortest period needed for symptom control.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Paracetamol/Ibuprofene Medipha can interact with several medicines.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of bleeding.
  • High‑dose aspirin aspirin: additive gastrointestinal toxicity.
  • Selective COX‑2 inhibitors (e.g., celecoxib): heightened cardiovascular risk.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors (e.g., enalapril): may reduce renal perfusion.
  • Diuretics (e.g., furosemide): potential for reduced kidney function.
  • Lithium: NSAID component can raise lithium serum levels.
  • Methotrexate: ibuprofen may delay clearance, increasing toxicity.

Frequently Asked Questions

Paracetamol/Ibuprofene Medipha is a combined oral formulation of ibuprofen and paracetamol that provides analgesic, antipyretic and anti‑inflammatory effects. It is commonly used to relieve mild‑to‑moderate pain such as headache, dental or musculoskeletal pain, and to reduce fever in adults and children when prescribed by a healthcare professional.

Ibuprofen blocks cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 enzymes, which reduces the production of prostaglandins that cause inflammation, pain and fever. The reduction of prostaglandins lessens the sensitisation of nerve endings and lowers body temperature, contributing to the overall symptom relief of the combination product.

The specific dose and dosing interval are determined by the prescribing clinician based on the patient’s age, weight, clinical condition and any concomitant therapies. Healthcare providers set the appropriate regimen and should follow local prescribing guidelines.

Safety in pregnancy and lactation depends on the trimester and individual risk factors. Ibuprofen is generally avoided in the third trimester, while paracetamol is considered relatively safe when used at recommended doses. Clinicians should evaluate the benefit‑risk balance before prescribing to pregnant or nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The combination offers additive analgesic and antipyretic effects, allowing lower individual doses of each agent while achieving comparable pain relief and fever reduction. This can reduce the risk of dose‑related side effects associated with higher single‑agent dosing, though the safety profile must still be monitored.

Store the product at temperatures below 25 °C in its original packaging. Protect it from moisture, direct sunlight and extreme humidity to maintain potency and prevent degradation.

The medication is taken orally, usually with a glass of water. It may be taken with or without food, although taking it with food can lessen gastrointestinal discomfort for some patients.

Serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity especially with overdose, renal impairment and anaphylaxis. Patients should seek immediate medical attention if they notice signs of these conditions.

Individuals with known hypersensitivity to ibuprofen, paracetamol or any excipients, those with active peptic ulcer disease, severe liver or kidney impairment, and patients on anticoagulant therapy without close monitoring should avoid this product unless directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibuprofen, Paracetamol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT